AdaptHealth (AHCO) Gains from Investment Securities (2019 - 2026)

AdaptHealth's Gains from Investment Securities history runs 8 years deep, the most recent figure standing at -$12.3 million for Q1 2026.

• In Q1 2026, Gains from Investment Securities fell 481.47% year-over-year to -$12.3 million; the TTM figure through Mar 2026 stood at $25.6 million (up 221.07% YoY), while the FY2025 annual figure was $37.9 million, up 1879.7% from the prior year.
• Gains from Investment Securities was -$12.3 million for Q1 2026 at AdaptHealth, down from $37.9 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $37.9 million in Q4 2025 to a low of -$15.1 million in Q4 2024.
• Historically, Gains from Investment Securities has averaged $1.2 million across 5 years, with a median of $981000.0 in 2023.
• The sharpest annual moves came in 2022 and 2023: Gains from Investment Securities surged 26209.68% in 2022, then sank 771.55% in 2023.
• A 5-year view of Gains from Investment Securities shows it stood at -$13000.0 in 2022, then surged by 17592.31% to $2.3 million in 2023, then slumped by 765.92% to -$15.1 million in 2024, then surged by 350.1% to $37.9 million in 2025, then sank by 132.44% to -$12.3 million in 2026.
• The last three Gains from Investment Securities figures came in at -$12.3 million (Q1 2026), $37.9 million (Q4 2025), and $3.2 million (Q1 2025), per Business Quant data.